EiRx Therapeutics increases stake

HEALTHCARE firm EiRx Therapeutics has increased its stake in Scottish cancer research company Auvation to 75.1%.

EiRx Therapeutics increases stake

The company, which plans to take full control of Auvation, has also secured a fresh injection of almost €145,000 from private equity group Aurora.

The funds raised will be used to provide additional working capital for the EiRx group and to continue the development of its drug discovery programme.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited